The pharmacology of VA21B7: an atypical 5-HT3 receptor antagonist with anxiolytic-like properties in animal models

1995 ◽  
Vol 117 (2) ◽  
pp. 137-148 ◽  
Author(s):  
I. Artaiz ◽  
G. Romero ◽  
A. Zazpe ◽  
B. Lasheras ◽  
J. Del Río ◽  
...  
Keyword(s):  
Animal Models ◽  
Receptor Antagonist

Effects of the selective 5-HT7 receptor antagonist SB-269970 in animal models of psychosis and cognition

2012 ◽  
Vol 228 (1) ◽  
pp. 211-218 ◽  
Author(s):  
Kerry A. Waters ◽  
Tania O. Stean ◽  
Beverley Hammond ◽  
David J. Virley ◽  
Neil Upton ◽  
...  
Keyword(s):  
Animal Models ◽  
Receptor Antagonist

scholarly journals ASP5736, a novel 5-HT5A receptor antagonist, ameliorates positive symptoms and cognitive impairment in animal models of schizophrenia

2014 ◽  
Vol 24 (10) ◽  
pp. 1698-1708 ◽  
Author(s):  
Mayako Yamazaki ◽  
Katsuya Harada ◽  
Noriyuki Yamamoto ◽  
Junko Yarimizu ◽  
Mayuko Okabe ◽  
...  
Keyword(s):  
Cognitive Impairment ◽  
Animal Models ◽  
Receptor Antagonist ◽  
Positive Symptoms

Effect of a New Cholecystokinin Receptor Antagonist Loxiglumide on Acute Pancreatitis in Two Experimental Animal Models

Pancreas ◽  
1990 ◽  
Vol 5 (3) ◽  
pp. 284-290 ◽  
Author(s):  
Satoshi Tani ◽  
Yoshinori Okabayashi ◽  
Takahiko Nakamura ◽  
Masatoshi Fujii ◽  
Hiroshi Itoh ◽  
...  
Keyword(s):  
Acute Pancreatitis ◽  
Animal Models ◽  
Receptor Antagonist ◽  
Experimental Animal ◽  
Experimental Animal Models ◽  
Cholecystokinin Receptor

scholarly journals ADN-1184, a monoaminergic ligand with 5-HT6/7 receptor antagonist action, exhibits activity in animal models of anxiety

2016 ◽  
Vol 389 (6) ◽  
pp. 593-602 ◽  
Author(s):  
Anna Partyka ◽  
Anna Wasik ◽  
Magdalena Jastrzębska-Więsek ◽  
Paweł Mierzejewski ◽  
Przemysław Bieńkowski ◽  
...  
Keyword(s):  
Animal Models ◽  
Receptor Antagonist ◽  
Animal Models Of Anxiety ◽  
Antagonist Action
Sign in / Sign up

Export Citation Format

Share Document